Overview
Mruk-MED I operates a medical center in Rzeszów, providing services through more than 14 specialist clinics, including oncology, cardiology and ophthalmology. Its clinics offer diagnostic imaging using magnetic resonance imaging and computed tomography, and provide services under Poland’s National Health Fund.
- ul. Langiewicza 61, 35-922 Rzeszów
- ul. Langiewicza 46, 35-922 Rzeszów
- ul. Partyzantów 28, 35-242 Rzeszów
- ul. Partyzantów 30a, 35-242 Rzeszów
- ul. Zbyszewskiego 15, 35-001 Rzeszów
- Monday–Thursday
- 7:00–20:00
- Friday
- 7:00–18:00
Financials
Revenue history (in m)
From the notes
| Current income tax (CIT due) | $77,750 |
Filing timeliness
1 of 4 financial statements was filed late (for 2022, 12 days late).
- 202503/07/2026
- 202415/07/2025
- 202312/07/2024
- 202227/07/2023
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Offer
- Specialist clinics
- Diagnostic imaging
- Magnetic resonance imaging
- Computed tomography
- Chemotherapy
- Mammography
Website technology
- Website
- Joomla
National Health Fund (NFZ) contracts
Mruk-MED I has been an NFZ healthcare provider since 2008. In 2026 it is performing 3 contracts with a total value of USD 18.17m. All its contracts were worth USD 118.45m in total.
NFZ contract value by year (in m USD)
| Type of care | NFZ branch | Contracts | Value in 2026 |
|---|---|---|---|
| Inpatient treatment | podkarpackie | 2 | USD 17.25m |
| Outpatient specialist care | podkarpackie | 1 | USD 927.20k |
NFZ waiting lists
This company's facilities run 26 NFZ waiting lists. Waiting time forecast by NFZ, as of 05.10.2026.
| Service | Facility | Waiting time | Urgent | Waiting | |
|---|---|---|---|---|---|
| Treatment of patients with B-cell lymphomas | Gen. Mariana Langiewicza 61 | no wait | no wait | 0 | |
| Treatment of patients with prostate cancer | Oddział Onkologiczny | no wait | no wait | 0 | |
| Treatment of patients with prostate cancer | Poradnia Chemioterapii | no wait | no wait | 0 | |
| Treatment of patients with ovarian, fallopian tube or peritoneal cancer | Poradnia Chemioterapii | no wait | no wait | 0 | |
| Treatment of patients with ovarian, fallopian tube or peritoneal cancer | Oddział Onkologiczny | no wait | no wait | 0 |
Authorized Representatives
Manner of representation
Each member of the management board is independently entitled to make declarations of will and sign on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Beata Madej Mrukage 66 | 49 | $661.80 | 49% |
Andrzej Krzysztof Mrukage 67 | 49 | $661.80 | 49% |
Others | 2 | $27.01 | 2% |
Andrzej Krzysztof Mruk and Beata Madej Mruk hold a combined 98% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2003-01-07.
54 1750 1224 0000 0000 3449 6048- 61 1600 1462 1819 8444 0000 0002
- 77 1600 1462 1819 8444 0000 0005
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Feb 11, 2022 | Transformation registered |
Public aid
53 public aid cases recorded, with a total value of $25,616.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 1, 2026 | Aid in the form of wage subsidies for employing workers with disabilities | –– | Prezes Zarządu Państwowego Funduszu Rehabilitacji Osób Niepełnosprawnych | |
| Aug 4, 2026 | Aid in the form of wage subsidies for employing workers with disabilities | –– | Prezes Zarządu Państwowego Funduszu Rehabilitacji Osób Niepełnosprawnych | |
| Jul 7, 2026 | Aid in the form of wage subsidies for employing workers with disabilities | –– | Prezes Zarządu Państwowego Funduszu Rehabilitacji Osób Niepełnosprawnych |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| ARS Medicalsp. z o.o. | $30,982,068.72 | arsmedical.pila.pl | ||
| Affidea Onkoterapiasp. z o.o. | $29,529,691.81 | affidea.pl | ||
| Urovitasp. z o.o. | $26,144,676.20 | urovita.pl | ||
| NU - Med GrupaS.A. | $25,775,184.94 | nu-med.pl | ||
| Polmed Diagnostykasp. z o.o. | $19,099,698.64 | polmeddiagnostyka.pl | ||
| Aldemed Centrum Medycznesp. z o.o. | $17,163,375.93 | aldemed.pl | ||
| Centrum Diagnostyki Medycznej Multi-MedS.A. | $14,036,138.38 | multimed.pl | ||
| NU-MED Centrum Diagnostyki I Terapii Onkologicznej Katowicesp. z o.o. | $13,481,571.79 | nu-med.pl | ||
| MR Diagnostic.Plsp. z o.o. + limited partnership | $8,293,716.80 | mrdiagnostic.pl | ||
| Almedsp. z o.o. | $6,233,400.88 | almed.com.pl |
FAQ
Last updated: 2026-10-05